Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Marampon

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Cells|April 3, 2021
MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-MycEleni Anastasiadou, Elena Messina, Tiziana Sanavia, et al.
Journal of Oncology|March 19, 2020
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines <i>In Vitro</i> and <i>In Vivo</i>Alessandro Colapietro, Giovanni Luca Gravina, Francesco Petragnano, et al.
Journal of Cancer Research and Clinical Oncology|February 1, 2019
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistanceFrancesco Marampon, Silvia Codenotti, Francesca Megiorni, et al.
International Journal of Molecular Sciences|October 13, 2021
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma CellsMatteo Cassandri, Silvia Pomella, Alessandra Rossetti, et al.
Frontiers in Cell and Developmental Biology|February 9, 2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiationClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Cells|September 23, 2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway InhibitorsSilvia Codenotti, Daniela Zizioli, Luca Mignani, et al.
International Journal of Radiation Biology|May 12, 2021
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtypeAlessandra Rossetti, Francesco Petragnano, Luisa Milazzo, et al.
Cancer Letters|July 21, 2019
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell linesFrancesco Marampon, Valentina Di Nisio, Ilaria Pietrantoni, et al.
Journal of Contemporary Brachytherapy|March 20, 2020
The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic reviewValentina Lancellotta, Francesca De Felice, Lisa Vicenzi, et al.
Current Issues in Molecular Biology|July 23, 2025
Microbiota Modulation of Radiosensitiveness and Toxicity in Gastrointestinal Cancers: What Radiation Oncologists Need to Know-A Review on Behalf of the Italian Association of Radiobiology (AIRB)Marco Lorenzo Bonù, Andrea Georgopulos, Marco Ramera, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Cells|April 3, 2021
MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-MycEleni Anastasiadou, Elena Messina, Tiziana Sanavia, et al.
Journal of Oncology|March 19, 2020
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines <i>In Vitro</i> and <i>In Vivo</i>Alessandro Colapietro, Giovanni Luca Gravina, Francesco Petragnano, et al.
Journal of Cancer Research and Clinical Oncology|February 1, 2019
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistanceFrancesco Marampon, Silvia Codenotti, Francesca Megiorni, et al.
International Journal of Molecular Sciences|October 13, 2021
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma CellsMatteo Cassandri, Silvia Pomella, Alessandra Rossetti, et al.
Frontiers in Cell and Developmental Biology|February 9, 2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiationClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Cells|September 23, 2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway InhibitorsSilvia Codenotti, Daniela Zizioli, Luca Mignani, et al.
International Journal of Radiation Biology|May 12, 2021
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtypeAlessandra Rossetti, Francesco Petragnano, Luisa Milazzo, et al.
Cancer Letters|July 21, 2019
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell linesFrancesco Marampon, Valentina Di Nisio, Ilaria Pietrantoni, et al.
Journal of Contemporary Brachytherapy|March 20, 2020
The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic reviewValentina Lancellotta, Francesca De Felice, Lisa Vicenzi, et al.
Current Issues in Molecular Biology|July 23, 2025
Microbiota Modulation of Radiosensitiveness and Toxicity in Gastrointestinal Cancers: What Radiation Oncologists Need to Know-A Review on Behalf of the Italian Association of Radiobiology (AIRB)Marco Lorenzo Bonù, Andrea Georgopulos, Marco Ramera, et al.
Pageof 16